Avidity RNA Revolution 2022 Investor Presentation

Avidity presents its vision and strategy for advancing RNA therapeutics through its proprietary AOC platform. The presentation covers preclinical and clinical development programs, with focus on improving treatment delivery for RNA-based therapeutics, including applications in rare genetic diseases like DM1.